Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Bone Marrow Transplantation
|
October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Blood Advances
|
February 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Haematologica
|
April 2, 2026
Hypomethylating agents plus venetoclax <i>versus</i> intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia
Guillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Blood Advances
|
January 26, 2026
Baseline IPSS-M vs Pretransplant Risk Downstaging as Prognostic Determinants in MDS Undergoing Allogeneic Transplantation
Luis E Aguirre, Haesook T Kim, Hany Elmariah, et al.
Blood Advances
|
March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy
Hannah Lust, Liora M Schultz, Soyang Kwon, et al.
Blood Advances
|
October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Yannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Bone Marrow Transplantation
|
October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Blood Advances
|
February 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Haematologica
|
April 2, 2026
Hypomethylating agents plus venetoclax <i>versus</i> intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia
Guillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Blood Advances
|
January 26, 2026
Baseline IPSS-M vs Pretransplant Risk Downstaging as Prognostic Determinants in MDS Undergoing Allogeneic Transplantation
Luis E Aguirre, Haesook T Kim, Hany Elmariah, et al.
Blood Advances
|
March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy
Hannah Lust, Liora M Schultz, Soyang Kwon, et al.
Blood Advances
|
October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Yannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 5